These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24352471)

  • 1. Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllers.
    Lai JI; Licht AF; Dugast AS; Suscovich T; Choi I; Bailey-Kellogg C; Alter G; Ackerman ME
    J Virol; 2014 Mar; 88(5):2799-809. PubMed ID: 24352471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors.
    Sadanand S; Das J; Chung AW; Schoen MK; Lane S; Suscovich TJ; Streeck H; Smith DM; Little SJ; Lauffenburger DA; Richman DD; Alter G
    AIDS; 2018 Feb; 32(4):443-450. PubMed ID: 29239894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.
    Ngo-Giang-Huong N; Candotti D; Goubar A; Autran B; Maynart M; Sicard D; Clauvel JP; Agut H; Costagliola D; Rouzioux C;
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1435-46. PubMed ID: 11679156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.
    French MA; Center RJ; Wilson KM; Fleyfel I; Fernandez S; Schorcht A; Stratov I; Kramski M; Kent SJ; Kelleher AD
    AIDS; 2013 Feb; 27(4):519-28. PubMed ID: 23364441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HIV-1 Gag-Specific IgG Antibodies With Natural Control of HIV-1 Infection in Individuals Not Carrying HLA-B*57: 01 Is Only Observed in Viremic Controllers.
    Tjiam MC; Morshidi MA; Sariputra L; Martin JN; Deeks SG; Tan DBA; Lee S; Fernandez S; French MA
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):e90-e92. PubMed ID: 28604502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral Controllers.
    Isitman G; Lisovsky I; Tremblay-McLean A; Kovacs C; Harris M; Routy JP; Bruneau J; Wainberg MA; Tremblay C; Bernard NF
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1079-1088. PubMed ID: 27499379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1.
    Tay MZ; Kunz EL; Deal A; Zhang L; Seaton KE; Rountree W; Eudailey JA; Heptinstall J; McRaven MD; Matias E; McGuire E; Yates NL; Perez LG; Montefiori DC; Overman RG; Hope TJ; Shen X; Kalilani L; Fouda GG; Tomaras GD; Permar SR
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.
    Chung AW; Mabuka JM; Ndlovu B; Licht A; Robinson H; Ramlakhan Y; Ghebremichael M; Reddy T; Goulder PJR; Walker BD; Ndung'u T; Alter G
    AIDS; 2018 Jun; 32(10):1207-1217. PubMed ID: 29620716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllers.
    Lambotte O; Pollara J; Boufassa F; Moog C; Venet A; Haynes BF; Delfraissy JF; Saez-Cirion A; Ferrari G
    PLoS One; 2013; 8(9):e74855. PubMed ID: 24086385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection.
    Rouers A; Klingler J; Su B; Samri A; Laumond G; Even S; Avettand-Fenoel V; Richetta C; Paul N; Boufassa F; Hocqueloux L; Mouquet H; Rouzioux C; Lambotte O; Autran B; Graff-Dubois S; Moog C; Moris A;
    EBioMedicine; 2017 Jul; 21():158-169. PubMed ID: 28615147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.
    Brown EP; Dowell KG; Boesch AW; Normandin E; Mahan AE; Chu T; Barouch DH; Bailey-Kellogg C; Alter G; Ackerman ME
    J Immunol Methods; 2017 Apr; 443():33-44. PubMed ID: 28163018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.
    Banerjee K; Klasse PJ; Sanders RW; Pereyra F; Michael E; Lu M; Walker BD; Moore JP
    AIDS Res Hum Retroviruses; 2010 Apr; 26(4):445-58. PubMed ID: 20377426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features.
    Cheng HD; Dowell KG; Bailey-Kellogg C; Goods BA; Love JC; Ferrari G; Alter G; Gach J; Forthal DN; Lewis GK; Greene K; Gao H; Montefiori DC; Ackerman ME
    Retrovirology; 2021 Oct; 18(1):35. PubMed ID: 34717659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees.
    Fischinger S; Dolatshahi S; Jennewein MF; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Michael N; Vasan S; Ackerman ME; Streeck H; Alter G
    JCI Insight; 2020 Nov; 5(21):. PubMed ID: 33031099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection.
    Muenchhoff M; Chung AW; Roider J; Dugast AS; Richardson S; Kløverpris H; Leslie A; Ndung'u T; Moore P; Alter G; Goulder PJR
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33361123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles.
    Catano G; Kulkarni H; He W; Marconi VC; Agan BK; Landrum M; Anderson S; Delmar J; Telles V; Song L; Castiblanco J; Clark RA; Dolan MJ; Ahuja SK
    PLoS One; 2008; 3(11):e3636. PubMed ID: 18982067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequencies of Circulating Th1-Biased T Follicular Helper Cells in Acute HIV-1 Infection Correlate with the Development of HIV-Specific Antibody Responses and Lower Set Point Viral Load.
    Baiyegunhi O; Ndlovu B; Ogunshola F; Ismail N; Walker BD; Ndung'u T; Ndhlovu ZM
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29793949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.
    Perez LG; Costa MR; Todd CA; Haynes BF; Montefiori DC
    J Virol; 2009 Aug; 83(15):7397-410. PubMed ID: 19458010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: mechanisms of HIV elite control in two African women.
    Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
    BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.